1. Home
  2. FXNC vs VNDA Comparison

FXNC vs VNDA Comparison

Compare FXNC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

N/A

Current Price

$28.75

Market Cap

258.1M

Sector

Finance

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

SELL

Current Price

$3.47

Market Cap

231.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FXNC
VNDA
Founded
1907
2002
Country
United States
United States
Employees
308
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
258.1M
231.0M
IPO Year
2012
2005

Fundamental Metrics

Financial Performance
Metric
FXNC
VNDA
Price
$28.75
$3.47
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
★ $33.00
$11.50
AVG Volume (30 Days)
12.7K
★ 1.2M
Earning Date
10-23-2026
10-28-2026
Dividend Yield
★ 2.63%
N/A
EPS Growth
★ 96.00
N/A
EPS
★ 1.93
N/A
Revenue
$7,717,000.00
★ $216,105,000.00
Revenue This Year
$7.52
$12.05
Revenue Next Year
$4.62
$30.61
P/E Ratio
$15.02
★ N/A
Revenue Growth
7.40
★ 8.72
52 Week Low
$23.71
$3.57
52 Week High
$33.24
$9.91

Technical Indicators

Market Signals
Indicator
FXNC
VNDA
Relative Strength Index (RSI) 37.27 32.18
Support Level $28.80 N/A
Resistance Level $30.57 $5.49
Average True Range (ATR) 0.89 0.23
MACD -0.19 -0.01
Stochastic Oscillator 16.91 0.00

Price Performance

Historical Comparison
FXNC
VNDA

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: